About 4,200 Canadians have cystic fibrosis. There are three gene-modifying drugs available — Symdeko, Kalydeco and Orkambi — that are believed to slow down lung damage caused by the disease. Access to all three medications is severely limited.
»»» Subscribe to The National to watch more videos here: https://www.youtube.com/user/CBCTheNational?sub_confirmation=1
Voice Your Opinion & Connect With Us Online:
The National Updates on Facebook: https://www.facebook.com/thenational
The National Updates on Twitter: https://twitter.com/CBCTheNational
»»» »»» »»» »»» »»»
The National is CBC Television’s flagship news program. Airing six days a week, the show delivers news, feature documentaries and analysis from some of Canada’s leading journalists.